GSI Lumonics to Sell Life Sciences Unit
GSI Lumonics Inc. of Kanata, Ontario, Canada, has announced that it will sell its biochip and microarray divisions to Packard BioScience Co. of Meriden, Conn., for cash and stock valued at $120 million. GSI's life sciences division represents about 5 percent of total GSI sales and about 75 of its 1400 employees.
Charles Winston, CEO of GSI, said the division will benefit from Packard's global distribution system.
Upon completion of the deal, Packard will be among the three largest providers of biochip and micro-array tools for genomic and proteomic analysis, said company CEO Emery Olcott.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024